Generics
VistaPharm Initiates Recall of Ulcer Medication Over Bacterial Contamination Concerns
The pharmaceutical landscape has witnessed several recalls initiated by the FDA due to drugs being contaminated with a spectrum of ...
Teva Wins License to Launch Generic Vivitrol in 2027 After Patent Settlement with Alkermes
Teva Pharmaceuticals has secured a pivotal victory in a patent dispute settlement with Alkermes, the manufacturer of Vivitrol. This settlement ...
Teva and Glenmark Agree to $255M Settlement with DOJ in Price-Fixing Case
Teva and Glenmark Pharmaceuticals, implicated in a price-fixing scheme, are facing substantial penalties and divestiture mandates after reaching a deferred ...
How Pfizer Defends Its Heart Drug Vyndamax from Generics
Just within four years of introducing their premium heart medication Vyndamax, Pfizer finds itself embroiled in a patent defense battle ...
As Vyvanse generics loom, Takeda exaggerates the progress of the dengue vaccine launch
As generics of the popular ADHD medication Vyvanse loom on the horizon, Takeda is looking to rely on newer launches ...
Cabometyx patent battle is resolved by Exelixis and Teva with a 2031 generic license
Source – Exelixis Exelixis, the company behind the successful cancer drug Cabometyx, has been actively defending its intellectual property. In ...
